David Feder

David Feder

Fundação e Faculdade de Medicina do ABC - Santo André / Brazil
Medical and Health Sciences / Pharmacology
AD Scientific Index ID: 829721
Foundation and Faculty of Medicine of ABC
person_outline David Feder's MOST POPULAR ARTICLES
1-) Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind …JF Howard Jr, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, ...The Lancet Neurology 16 (12), 976-986, 20173912017
2-) The use of vancomycin with its therapeutic and adverse effects: a reviewFR Bruniera, FM Ferreira, LR Saviolli, MR Bacci, D Feder, ...Eur Rev Med Pharmacol Sci 19 (4), 694-700, 20152342015
3-) Long‐term safety and efficacy of eculizumab in generalized myasthenia gravisS Muppidi, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ...Muscle & nerve 60 (1), 14-24, 20191272019
4-) A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophyN Goemans, E Mercuri, E Belousova, H Komaki, A Dubrovsky, ...Neuromuscular Disorders 28 (1), 4-15, 20181312018
5-) IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patientsMR Bacci, RCP Leme, NPC Zing, N Murad, F Adami, PF Hinnig, D Feder, ...Brazilian Journal of Medical and Biological Research 48 (5), 427-432, 20151212015